In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 63 for your search:
Country:  U.S.A.
Trial Type:  Screening
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Health services research, Screening
Status: Active
Age: 45 to 65
Sponsor: Other
Protocol IDs: CDC-NCCDPHP-2504, NCT00207636

2.

Phase: Phase III
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 18 to 64
Sponsor: NCI, Other
Protocol IDs: P01CA109091-01A1, NCT00760721

3.

Phase: Phase III
Type: Screening
Status: Active
Age: 28 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113617, NCT01190176

4.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014

5.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 50 to 80
Sponsor: NCI
Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653

7.

Phase: Phase II
Type: Health services research, Screening
Status: Active
Age: 50 to 120
Sponsor: Other
Protocol IDs: Oncimmune-2550, NCT01700257

8.

Phase: Phase II
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: NCI, Other
Protocol IDs: UH3CA188640, 1UH2AT007782-01, NCT01742065

9.

Phase: Phase II
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MC1374, 13-005106, NCT01991977

10.

Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: P50CA83636-01, 6973, NCT01121640

12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095

13.

Phase: No phase specified
Type: Screening
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-02-C-0313, NCT00049621

14.

Phase: No phase specified
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: DAMD17-03-1-0447, NCT00117663

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Screening
Status: Active
Age: Over 50
Sponsor: Other
Protocol IDs: CDR0000456198, NYU-H-8896-06-B, NCT00301119

16.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CASE1105, P30CA043703, NCT00445445

17.

Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 070504, NCT00534053

18.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening, Tissue collection/Repository
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000583154, VU-VICC-GI-0294, VU-VICC-020603, VU-VICC-020531, VICC-GI-0294, NCT00625066

19.

Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR0002, 00371, NCT00613262

20.

Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 35 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC0001, NCT00649337

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 21 to 50
Sponsor: Other
Protocol IDs: BCA-003, CA126441, CA083597, NCT00671385

22.

Phase: No phase specified
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: J0139 00-04-14-10, J0139, NCT00714701

23.

Phase: No phase specified
Type: Screening
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: H-20395, 5 P50 CA091846 07 (PP-S2), NCT00848627

24.

Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 00-60, NYU H#9541, NCT00849199

25.

Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: HIC0809004192, NCT00859625
1    
New Search